Risk of thrombotic events in immune thrombocytopenia patients treated with thrombopoietic agents: a systematic review and meta-analysis

BACKGROUND: Immune thrombocytopenia (ITP), which is a well-known hemorrhagic disorder characterized by low platelet counts, has been shown to be associated with the risk of thrombosis. Thrombopoietic agents (TAs) are extensively used as second-line treatments for ITP, effectively reducing the risk o...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Yu, Xia, Zhinan, Zhou, Jie, Hu, Yutao, Yue, Ming, Wang, Yuyong, Hu, Mengjiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290365/
https://www.ncbi.nlm.nih.gov/pubmed/37353791
http://dx.doi.org/10.1186/s12959-023-00509-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290365/
https://www.ncbi.nlm.nih.gov/pubmed/37353791
http://dx.doi.org/10.1186/s12959-023-00509-z

Ejemplares similares